Vericel price target raised to $56 from $54 at Ladenburg

Ladenburg raised the firm’s price target on Vericel (VCEL) to $56 from $54 and keeps a Buy rating on the shares. The company delivered strong Q3 results, marked by record revenue, substantial margin expansion, and key regulatory advancements, the analyst tells investors in a research note.